The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hensley Mark Earl since 2026.
This trader's CIK number is 2065816.
At the time of last reporting, Hensley Mark Earl was the Chief Operating Officer of Heron Therapeutics, Inc. /de/. (stock ticker symbol HRTX).
Also see all insider trading activities at Heron Therapeutics, Inc. /de/.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | HRTX | 0 | $0 | 0 | $0 | 11,770 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-30 | HRTX | Option Ex | 11,770 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hensley Mark Earl (Chief Operating Officer of Heron Therapeutics, Inc. /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.